WANY
ALXN

Wealthspire Advisors (New York)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,829
Closed -$280K – 713
2021
Q1 		$280K Buy
+1,829
New +$280K 0.01% 571
2019
Q1 		– Sell
-145
Closed -$14K – 885
2018
Q4 		$14K Buy
+145
New +$14K ﹤0.01% 429